"Evaluation of ELITE InGenius® integrative system for detection, quantification and monitoring of HIV-1 RNA in Cerebrospinal Fluid."

Introduction: Human Immunodeficiency virus (HIV) is effectively suppressed in the blood by the antiretroviral therapy in people living with HIV, but in rare cases can be present in some tissues and body fluids. In recent years, integrated systems were validated for detecting HIV-1 in plasma or serum. but not in cerebrospinal fluid (CSF). we evaluated the performance of ELITE ingenius (R) in comparison with the cobas (R) in this area. methods: to test the diagnostic accuracy of the HIV-1 ELITe MGB (R) kit on CSF samples, we tested CSF samples previously characterised with the cobras (R) HIV1 test. archived CSF samples were also spiked with serial dilutions of the 4th WHO International standard for HIV-1 NAT and assays and tested to assess the repeatability and reproducibility of the ELITechGroup assay. results: the HIV-1 ELITe MGB (R) Kit confirmed all the HIV-1 negative CSF samples from patients HIV positive in plasma and from non-HIV1 patients. all the CSF samples that were HIV-1 positive by the cobas (R), were confirmed positive by the ELITe ingenius (R). concordance across the methods was also observed when processing the CSF dilutions spiked at medium-low titre, mimicking HIV-1 low-load infections. conclusions: the two systems were equivalent in the detection and quantification of HIV-1 RNA in CSF samples.